Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 20,319 | 17,146 | 12,090 | 13,546 | 22,945 |
| Cost of Goods | 4,206 | 4,980 | 3,020 | 3,270 | 7,490 |
| Gross Profit | 15,120 | 12,160 | 9,060 | 10,260 | 14,690 |
| Operating Expenses | 12,811 | 12,240 | 12,000 | 9,920 | 8,480 |
| Operating Income | 3,508 | 906 | -2,910 | 626 | 7,465 |
| Interest Expense | 927 | 900 | 830 | 750 | 870 |
| Other Income | 1,705 | 514 | 800 | 904 | 345 |
| Pre-tax Income | 4,286 | 520 | -2,940 | 780 | 6,940 |
| Income Tax | 638 | 410 | 70 | 340 | -2,282 |
| Net Income Continuous | 1,304 | 89 | -2,248 | 4 | 5,821 |
| Net Income | $1,304 | $89 | $-2,248 | $4 | $5,821 |
| EPS Basic Total Ops | 0.02 | 0.00 | -0.04 | 0.00 | 0.10 |
| EPS Basic Continuous Ops | 0.02 | 0.00 | -0.04 | 0.00 | 0.10 |
| EPS Diluted Total Ops | 0.02 | 0.00 | -0.04 | 0.00 | 0.10 |
| EPS Diluted Continuous Ops | 0.02 | 0.00 | -0.04 | 0.00 | 0.10 |
| EBITDA(a) | $15,438 | $-7,414 | $-1,070 | $3,316 | $9,175 |